Dr. Willmar Schwabe GmbH & Co. KG
Sunday 7 April 2024
(12:45-13:30 CEST)
F6-F7
in person live-streamed
Satellite Symposium
Anxiety Meets Depression – the Role of Neuroplasticity and Co-morbidity
Chair: O.Univ.Prof.Dr.Dr.h.c. Siegfried Kasper, Austria12:45-12:50 | Welcome & Introduction | Siegfried Kasper, Austria |
12:50-13:05 | Neuroplasticity in Anxiety and Depression – Current Research | Anne Eckert, Switzerland |
13:05-13:20 | Co-Morbidity of Anxiety and Depression – Different Dimensions and Resulting Treatment Approaches | Lucie Bartova, Austria |
13:20-13:30 | Discussion | Siegfried Kasper, Austria |
Gedeon Richter & Recordati
Sunday 7 April 2024
(12:45-13:30 CEST)
F8
in person
Satellite Symposium
Schizophrenia and the Management of Psychiatric Comorbidities
Chair: Christoph Correll, Germany/USA
12:45-13:05 | Beyond the Textbook: the Challenges of Psychiatric Comorbidities | Christoph Correll, Germany/USA |
13:05-13:25 | Mix & Match: Combinations for Comorbidities | Jelena Vrublevska, Latvia |
13:25-13:30 | Q&A | All |
Boehringer Ingelheim
Sunday 7 April 2024
(13:15-14:45 CEST)
P1-P2-P3
in person live-streamed
Satellite Symposium
Starting Conversations About Cognitive Health in Schizophrenia
Chair: János Réthelyi, Hungary
13:15-13:30 | Starting Conversations About Cognitive Health in Schizophrenia | János Réthelyi, Hungary |
13:30-14:00 | The Many Faces of Cognitive Health: Experiences of Patients and Caregivers | Péter Kéri, Hungary / John Saunders, Ireland / Alice Medalia, USA |
14:00-14:15 | Using a Cognitive Health Lens: How to Face Misconceptions and Unmet Needs | Alice Medalia, USA |
14:15-14:30 | How Might Prioritizing and Addressing Cognitive Health Benefit Patients? | Peter Falkai, Germany |
14:30-14:45 | Panel Q&A | All |
Janssen Pharmaceutica NV
Sunday 7 April 2024
(13:15-14:45 CEST)
F1-F2-F3
in person live-streamed
Satellite Symposium
Structured Patient Management in TRD: From Guidelines to the Clinic
Chair: Phillip Gorwood, France & Roger McIntyre, Canada
13:15-13:20 | Welcome and Introduction | Phillip Gorwood, France |
13:20-13:40 | Using Clinical Guidelines and Current Research to Optimise Management of Patients with TRD in the Short- and Long-term | Roger McIntyre, Canada |
13:40-14:20 | Illustrating Practical Management of TRD with Patient Cases | Phillip Gorwood, France / Lucie Bartova, Austria |
14:20-14:40 | Panel Discussion Incorporating Audience Q&A | All |
14:40-14:45 | Closing Remarks | Roger McIntyre, Canada |
Angelini Pharma SpA
Sunday 7 April 2024
(16:30-17:00 CEST)
Exhibition
in person
Product Theatre
Do you DARE to Go Beyond Symptom Management in Schizophrenia?
Chair: Gregory W. Mattingly, USA
16:30-17:00 | Do you DARE to Go Beyond Symptom Management in Schizophrenia? | Gregory W. Mattingly, USA |
Gedeon Richter & Recordati
Monday 8 April 2024
(12:45-13:15 CEST)
F9
in person
Product Theatre
New Treatment Options for Dual Schizophrenia
Chair: Nestor Szerman, Spain
12:45-13:15 | New Treatment Options for Dual Schizophrenia and Q&A | Nestor Szerman, Spain |
Janssen Pharmaceutica NV
Monday 8 April 2024
(13:15-14:45 CEST)
F1-F2-F3
in person live-streamed
Satellite Symposium
Aspiring for More in Schizophrenia: Using Modern Therapies in Clinical Practice
Chair: Silvana Galderisi, Italy
13:15-13:30 | Welcome and Introduction | Silvana Galderisi, Italy |
13:30-13:50 | Reaching for Improved Maintenance Outcomes: the Latest Real-world Data with Long-acting Therapies | Martha Sajatovic, USA |
13:50-14:10 | Looking at the Long-term: The Role of Modern Therapeutic Strategies | Pedro Sanchez-Gomez, Spain |
14:10-14:30 | Realising Patient Goals: the Benefits of Long-acting Therapies | Vassilis Martiadis, Italy |
14:30-14:42 | Full Faculty Discussion | Silvana Galderisi, Italy |
14:42-14:45 | Closing Remarks | Silvana Galderisi, Italy |
Boehringer Ingelheim
Monday 8 April 2024
(13:15-14:45 CEST)
P1-P2-P3
in person live-streamed
Satellite Symposium
From Patient Experiences to Future Perspectives: a Focus on Overwhelming Negative Emotions
Chair: TBC
13:15-13:25 | Introduction | Allan Young, UK |
13:25-13:50 | Treatment Deep Dive: Challenges and Unmet Needs | Livia De Picker, Belgium |
13:50-14:10 | Taking a Closer Look at the Underlying Brain Networks | Rakesh Jain, USA |
14:10-14:30 | Novel Treatment Targets to Improve Outcomes | George Papakostas, USA |
14:30-14:45 | Panel Q&A | All |
Lundbeck
Monday 8 April 2024
(13:15-14:45 CEST)
F6-F7
in person live-streamed
Satellite Symposium
Tailoring Clinical Treatment Strategies for Patients with Major Depressive Disorder (MDD) and Co-morbidities
Chair: Andrea Fagiolini, Italy & Barbara Hochstrasser, Switzerland
13:15-13:30 | Exploring the Impact of Co-morbidities in MDD | Susana Sousa Almeida, Portugal |
13:30-13:35 | Live Q&A | All |
13:35-13:50 | Navigating Co-morbidities in MDD: How can we Best Optimise Treatment Strategies? | Andrea Fagiolini, Italy |
13:50-13:55 | Live Q&A | All |
13:55-14:10 | Addressing Challenges in the Clinical Management of Elderly Patients with MDD | Luis Agüera Ortiz, Spain |
14:10-14:15 | Live Q&A | All |
14:15-14:30 | Can Alternative Antidepressant Formulations Provide Benefits to Patients with MDD and Co-morbidities? | Barbara Hochstrasser, Switzerland |
14:30-14:45 | Live Q&A | All |
Idorsia Pharmaceuticals Ltd
Monday 8 April 2024
(13:45-14:45 CEST)
F8
in person
Satellite Symposium
Dreams of Better Sleep: from Insomnia Guidelines to Real-World Evidence
Chair: Dieter Kunz, Germany
13:45-13:50 | Welcome and introduction | Dieter Kunz, Germany |
13:50-14:05 | Mastering CID (Chronic Insomnia Disorder) Management: Diagnosis, Evidence and Guidelines | Pierre-Alexis Geoffroy, France |
14:05-14:20 | Regulating Wake Signalling: Understanding the Orexin Pathway and Daridorexant in the Treatment of Chronic Insomnia Disorder | Dieter Kunz, Germany |
14:20-14:35 | A Psychiatrist’s View on Daridorexant: Real-world Evidence in Patients with Co-morbidities | Laura Palagini, Italy |
14:35-14:45 | Q&A and Panel Discussion | All |
Viatris
Monday 8 April 2024
(18:45-19:30 CEST)
F6-F7
in person live-streamed
Satellite Symposium
Taming the Black Dog: Focusing on Aspects of Major Depressive Disorder that May be Elusive
Chair: Christoph Correll, Germany/USA18:45-18:50 | Introduction | Christoph Correll, Germany/USA |
18:50-19:05 | Anhedonia, Amotivation and Low Energy in MDD | Ofer Agid, Canada |
19:05-19:20 | MDD Across a Woman’s Lifespan: Focus on Reproductive Age Group | Kathryn Abel, UK |
19:20-19:30 | Q&A and Conclusion | All |